Skip to main content
. 2023 Apr 24;14:1180509. doi: 10.3389/fimmu.2023.1180509

Table 2.

Underlying or associated conditions in secondary warm AIHA.

Lymphoproliferative disorders B-cell lymphoma (Chronic lymphocytic leukemia, non-Hodgkin B-cell lymphomas)
T-cell lymphoma (T-LGL leukemia, angioimmunoblastic T-cell lymphoma)
Hodgkin lymphoma
Castleman disease
Other hematologic disorders Myeloid neoplasms (Myelodysplastic syndrome, myelofibrosis)
An associated immune cytopenia, usually ITP (Evans’syndrome)
Solid tumors Ovarian dermoid cyst or carcinoma
Thymoma
Non-hematologic autoimmune and inflammatory diseases Rheumatologic diseases (SLE, Rheumatoid arthritis, Sjögren syndrome)
Antiphospholipid syndrome
Autoimmune hepatitis
Ulcerative colitis
Sarcoidosis
Eosinophilic fasciitis
Primary immunodeficiencies Common variable immunodeficiency
Autoimmune lymphoproliferative syndrome
Infections Viruses (EBV, hepatitis, CMV, HIV, SARS-CoV-2)
Bacteria (Tuberculosis, brucellosis)
Protozoa (Babesiosis)
Transplantations Allogenic bone marrow transplantation
Organ transplantation (Liver, small bowel)

Some ultra-rare conditions have been omitted. CMV, cytomegalovirus; EBV, Epstein-Barr virus; HIV, human immunodeficiency virus; ITP, immune thrombocytopenia; LGL, large granular lymphocyte; SARS-CoV, severe adult respiratory syndrome corona virus; SLE, systemic lupus erythematosus.